KRAS and LKB1 comutant NSCLC emulates claudin-low breast cancer, and GFPT2 was reported in different studies to be the key player in boosting the malignancy of this type of malignant lung cancer (73, 74). This evidence concerns the gene STK11 and breast cancer.